The SARM1 targeting therapeutics market is project..

1 y - Translate

The SARM1 targeting therapeutics market is projected to grow at a CAGR of 102.1%, during the period 2033-2040, claims Roots Analysis

SARM1 inhibitors, having demonstrated the ability to prevent axonal degeneration, are being evaluated for the treatment of a number of neurodegenerative disorders. Once approved, these therapies are likely to capture a significant market share

For additional details, please visit https://www.rootsanalysis.com/....reports/sarm1-inhibi or email salesRoots Analysis.com

SARM1 Inhibitors Market | Industry Analysis | Market Size | 2040

SARM1 Inhibitors market, driven by active research and growing pipeline, is anticipated to grow at over 100% CAGR after first approval in 2033

Comment